Racecadotril - Bioproject
Alternative Names: Acetorphan; Hidrasec; Racemic acetorphan; Tiorfan; Tiorfast; TiorfixLatest Information Update: 29 Nov 2022
At a glance
- Originator Bioprojet
- Developer Abbott Laboratories; Bago; Bioprojet; Ferrer; GSK; Leti; Nordic Drugs; Takeda
- Class Antidiarrhoeals; Antisecretories; Benzyl compounds; Esters; Small molecules; Sulfhydryl compounds; Sulfur amino acids
- Mechanism of Action Neprilysin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diarrhoea
Most Recent Events
- 29 Nov 2022 No development reported - Phase-III for Diarrhoea (In adolescents, In children, In infants) in Russia (PO)
- 29 Nov 2022 No development reported - Phase-III for Diarrhoea (In children, In infants) in Taiwan (PO)
- 28 May 2020 No recent reports of development identified for phase-I development in Diarrhoea(In children, In volunteers) in France (PO, Suspension)